Susanna Bormioli

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.

Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.

Journal: Panminerva medica

Published: March 11, 2022

Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.

Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: February 03, 2022

Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA.

Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA.

Journal: Journal of investigational allergology & clinical immunology

Published: December 22, 2021

Management of patients with severe asthma: results from a survey among allergists and clinical immunologists of the Central Italy Inter-Regional Section of SIAAIC.

Management of patients with severe asthma: results from a survey among allergists and clinical immunologists of the Central Italy Inter-Regional Section of SIAAIC.

Journal: Clinical and molecular allergy : CMA

Published: August 31, 2021

Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis.

Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis.

Journal: Molecules (Basel, Switzerland)

Published: May 13, 2021

Effect of dupilumab treatment in a severe asthma patient with EGPA.

Effect of dupilumab treatment in a severe asthma patient with EGPA.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 16, 2021

Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?

Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?

Journal: International journal of molecular sciences

Published: March 05, 2021

Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.

Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.

Journal: Clinical and experimental immunology

Published: March 03, 2021

Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis.

Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis.

Journal: Scientific reports

Published: February 16, 2021

Mechanisms of Drug Desensitization: Not Only Mast Cells.

Mechanisms of Drug Desensitization: Not Only Mast Cells.

Journal: Frontiers in pharmacology

Published: August 03, 2020

Immunogenicity-unwanted immune responses to biological drugs - can we predict them?

Immunogenicity-unwanted immune responses to biological drugs - can we predict them?

Journal: Expert review of clinical pharmacology

Published: May 21, 2020

Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis.

Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis.

Journal: Allergy, asthma & immunology research

Published: February 11, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026